Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Income from Continuing Operations came in at 13382000.0 in Q1 2026, up 35.38% year-on-year from 9884486.05 in Q1 2025, and down 411.74% quarter-over-quarter from 2615000.0 in Q4 2025.

Establishment Labs Holdings (ESTA) Income from Continuing Operations (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Income from Continuing Operations history runs 10 years deep, the most recent figure standing at 13382000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 35.38% year-over-year to 13382000.0 in Q1 2026; TTM through Mar 2026 was 43736000.0, a 50.92% increase from a year earlier, with the FY2025 full-year figure at 51064000.0, up 39.64% from the prior year.
  • Income from Continuing Operations slipped to 13382000.0 in Q1 2026 per ESTA's latest filing, from 2615000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 2615000.0 in Q4 2025 and bottomed at 37106000.0 in Q2 2022.
  • The 5-year median for Income from Continuing Operations is 16682000.0 (2024), against an average of 17809000.0.
  • Across the five-year window, Income from Continuing Operations sank 597.22% in 2022 and soared 92.43% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 13562000.0 in 2022, then plunged by 51.47% to 20542000.0 in 2023, then sank by 68.1% to 34531000.0 in 2024, then surged by 92.43% to 2615000.0 in 2025, then tumbled by 411.74% to 13382000.0 in 2026.
  • Per Business Quant, the three latest ESTA Income from Continuing Operations figures stand at 13382000.0 (Q1 2026), 2615000.0 (Q4 2025), and 11146000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.08 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 745.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 380.70 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 199.50 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 273.95 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 411.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Establishment Labs Holdings 2.73 Bn 2.66 Bn 42.34 Mn -13.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.38 Mn
Dec 31, 2025 -2.62 Mn
Sep 30, 2025 -11.15 Mn
Jun 30, 2025 -16.59 Mn
Mar 31, 2025 -20.71 Mn
Dec 31, 2024 -34.53 Mn
Sep 30, 2024 -16.68 Mn
Jun 30, 2024 -17.18 Mn
Mar 31, 2024 -16.20 Mn
Dec 31, 2023 -20.54 Mn
Sep 30, 2023 -29.27 Mn
Jun 30, 2023 -16.75 Mn
Mar 31, 2023 -11.94 Mn
Dec 31, 2022 -13.56 Mn
Sep 30, 2022 -18.61 Mn
Jun 30, 2022 -37.11 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -14.19 Mn
Sep 30, 2021 -14.68 Mn
Jun 30, 2021 -5.32 Mn